BioSpace News Archive

Collegium Pharmaceutical, Inc. announced that management will present at the H.C. Wainwright Global Investment Conference being held at the Fontainebleau Miami Beach Hotel from May 23-26, 2022.

JenaValve Technology, Inc. announced the appointment of Kari Moore as the Company’s CFO effective May 10th, 2022.

Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on hematopoietic cell transplant therapies, today announced the dosing of the first patient in the Company’s sponsored research of the Center for Definitive and Curative Medicine (CDCM) at the Stanford University School of Medicine for the study of JPS191 as a conditioning agent in the treatment of Fanconi Anemia.

Agile Therapeutics, Inc. will present at the H.C. Wainwright Global Investment Conference taking place May 23-May 26, 2022 in Miami, FL.

Protara Therapeutics, Inc., a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, announced that management will present at the H.C. Wainwright Global Investment Conference being held May 23 through May 26, 2022.

Entasis Therapeutics Holdings Inc. (Nasdaq: ETTX), a late-stage clinical biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced that the company presented data highlights from its pivotal Phase 3 ATTACK trial at the American Thoracic Society (ATS) annual conference.

Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), today announced that the Company will participate in the following upcoming scientific and patient advocacy conferences.

Madrigal Pharmaceuticals, Inc. announced its management team will participate in two upcoming investor conferences.

Catalyst Pharmaceuticals, Inc. announced that Patrick J. McEnany, Chairman and CEO of Catalyst, along with other members of the management team, will participate at two upcoming conferences.

Merus N.V. announced that Bill Lundberg, M.D., President, Chief Executive Officer of Merus, will present at the H.C. Wainwright Global Investment Conference.